178 related articles for article (PubMed ID: 14593499)
1. Signal transducer and activator of transcription 6 (Stat6) and CD1: inhibitors of immunosurveillance against primary tumors and metastatic disease.
Ostrand-Rosenberg S; Sinha P; Clements V; Dissanayake SI; Miller S; Davis C; Danna E
Cancer Immunol Immunother; 2004 Feb; 53(2):86-91. PubMed ID: 14593499
[TBL] [Abstract][Full Text] [Related]
2. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway.
Terabe M; Matsui S; Noben-Trauth N; Chen H; Watson C; Donaldson DD; Carbone DP; Paul WE; Berzofsky JA
Nat Immunol; 2000 Dec; 1(6):515-20. PubMed ID: 11101874
[TBL] [Abstract][Full Text] [Related]
3. Resistance to metastatic disease in STAT6-deficient mice requires hemopoietic and nonhemopoietic cells and is IFN-gamma dependent.
Ostrand-Rosenberg S; Clements VK; Terabe M; Park JM; Berzofsky JA; Dissanayake SK
J Immunol; 2002 Nov; 169(10):5796-804. PubMed ID: 12421960
[TBL] [Abstract][Full Text] [Related]
4. CD1d-restricted natural killer T cells can down-regulate tumor immunosurveillance independent of interleukin-4 receptor-signal transducer and activator of transcription 6 or transforming growth factor-beta.
Terabe M; Khanna C; Bose S; Melchionda F; Mendoza A; Mackall CL; Helman LJ; Berzofsky JA
Cancer Res; 2006 Apr; 66(7):3869-75. PubMed ID: 16585215
[TBL] [Abstract][Full Text] [Related]
5. Role of IL-13 in regulation of anti-tumor immunity and tumor growth.
Terabe M; Park JM; Berzofsky JA
Cancer Immunol Immunother; 2004 Feb; 53(2):79-85. PubMed ID: 14610620
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.
Sinha P; Clements VK; Ostrand-Rosenberg S
Cancer Res; 2005 Dec; 65(24):11743-51. PubMed ID: 16357187
[TBL] [Abstract][Full Text] [Related]
7. Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression.
Sinha P; Clements VK; Miller S; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2005 Nov; 54(11):1137-42. PubMed ID: 15877228
[TBL] [Abstract][Full Text] [Related]
8. Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13.
Park JM; Terabe M; van den Broeke LT; Donaldson DD; Berzofsky JA
Int J Cancer; 2005 Mar; 114(1):80-7. PubMed ID: 15523692
[TBL] [Abstract][Full Text] [Related]
9. Stat6 signaling promotes protective immunity against Trichinella spiralis through a mast cell- and T cell-dependent mechanism.
Urban JF; Schopf L; Morris SC; Orekhova T; Madden KB; Betts CJ; Gamble HR; Byrd C; Donaldson D; Else K; Finkelman FD
J Immunol; 2000 Feb; 164(4):2046-52. PubMed ID: 10657657
[TBL] [Abstract][Full Text] [Related]
10. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.
Crowe NY; Smyth MJ; Godfrey DI
J Exp Med; 2002 Jul; 196(1):119-27. PubMed ID: 12093876
[TBL] [Abstract][Full Text] [Related]
11. A novel immunoregulatory axis of NKT cell subsets regulating tumor immunity.
Berzofsky JA; Terabe M
Cancer Immunol Immunother; 2008 Nov; 57(11):1679-83. PubMed ID: 18369622
[TBL] [Abstract][Full Text] [Related]
12. Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile.
Jankovic D; Kullberg MC; Noben-Trauth N; Caspar P; Paul WE; Sher A
J Immunol; 2000 Mar; 164(6):3047-55. PubMed ID: 10706693
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-4 receptor alpha chain and STAT6 signaling inhibit gamma interferon but not Th2 cytokine expression within schistosome granulomas.
Metwali A; Blum A; Elliott DE; Weinstock JV
Infect Immun; 2002 Oct; 70(10):5651-8. PubMed ID: 12228294
[TBL] [Abstract][Full Text] [Related]
14. Stat6 and IRS-2 cooperate in interleukin 4 (IL-4)-induced proliferation and differentiation but are dispensable for IL-4-dependent rescue from apoptosis.
Wurster AL; Withers DJ; Uchida T; White MF; Grusby MJ
Mol Cell Biol; 2002 Jan; 22(1):117-26. PubMed ID: 11739727
[TBL] [Abstract][Full Text] [Related]
15. Blockade of TGF-beta enhances tumor vaccine efficacy mediated by CD8(+) T cells.
Takaku S; Terabe M; Ambrosino E; Peng J; Lonning S; McPherson JM; Berzofsky JA
Int J Cancer; 2010 Apr; 126(7):1666-74. PubMed ID: 19830696
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.
Terabe M; Matsui S; Park JM; Mamura M; Noben-Trauth N; Donaldson DD; Chen W; Wahl SM; Ledbetter S; Pratt B; Letterio JJ; Paul WE; Berzofsky JA
J Exp Med; 2003 Dec; 198(11):1741-52. PubMed ID: 14657224
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinoma.
Ostrand-Rosenberg S; Grusby MJ; Clements VK
J Immunol; 2000 Dec; 165(11):6015-9. PubMed ID: 11086031
[TBL] [Abstract][Full Text] [Related]
18. Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease.
Sinha P; Clements VK; Ostrand-Rosenberg S
J Immunol; 2005 Jan; 174(2):636-45. PubMed ID: 15634881
[TBL] [Abstract][Full Text] [Related]
19. Development of colitis in signal transducers and activators of transcription 6-deficient T-cell receptor alpha-deficient mice: a potential role of signal transducers and activators of transcription 6-independent interleukin-4 signaling for the generation of Th2-biased pathological CD4+ betabetaT cells.
Okuda Y; Takahashi I; Kim JK; Ohta N; Iwatani K; Iijima H; Kai Y; Tamagawa H; Hiroi T; Kweon MN; Kawano S; Takeda K; Akira S; Sasaki Y; Hori M; Kiyono H
Am J Pathol; 2003 Jan; 162(1):263-71. PubMed ID: 12507909
[TBL] [Abstract][Full Text] [Related]
20. Stat6 regulation of in vivo IL-4 responses.
Finkelman FD; Morris SC; Orekhova T; Mori M; Donaldson D; Reiner SL; Reilly NL; Schopf L; Urban JF
J Immunol; 2000 Mar; 164(5):2303-10. PubMed ID: 10679064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
